Institutional Ownership Cullinan Oncology, Inc. (CGEM)
This table provides information about the institutional ownership of Cullinan Oncology, Inc. (CGEM). We have compiled data on the 153 institutions that hold shares in the stock, with a total of 66.5 Million shares, which have been reported (via 13F filing form) to have a value of $455 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
7,648,268
shares
|
$52.3 Million
11.28% of portfolio
|
Q3 2021
Reduced 3.36%
|
|
|
Bvf Inc
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
5,750,683
shares
|
$39.3 Million
1.7% of portfolio
|
Q2 2024
Added 79.89%
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
Aug 14, 2025 Q2 2025 |
4,400,842
shares
|
$30.1 Million
9.81% of portfolio
|
Q2 2025
Added 36.85%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
3,855,552
shares
|
$26.4 Million
0.67% of portfolio
|
Q2 2025
Reduced 0.14%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,550,207
shares
|
$24.3 Million
0.0% of portfolio
|
Q2 2024
Added 46.16%
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
3,414,189
shares
|
$23.4 Million
15.23% of portfolio
|
Q2 2023
Added 1.93%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,020,100
shares
|
$20.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.65%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
2,613,693
shares
|
$17.9 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.86%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Aug 11, 2025 Q2 2025 |
2,385,972
shares
|
$16.3 Million
9.73% of portfolio
|
Q2 2025
Reduced 2.05%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
2,228,160
shares
|
$15.2 Million
0.0% of portfolio
|
Q2 2025
Added 0.38%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
2,095,998
shares
|
$14.3 Million
1.88% of portfolio
|
Q2 2025
Reduced 10.37%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,923,855
shares
|
$13.2 Million
0.52% of portfolio
|
Q1 2025
Reduced 0.96%
|
|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,705,960
shares
|
$11.7 Million
0.2% of portfolio
|
Q3 2024
Added 62.07%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,607,592
shares
|
$11 Million
0.0% of portfolio
|
Q2 2025
Reduced 8.28%
|
|
|
Vr Adviser, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,379,965
shares
|
$9.44 Million
2.06% of portfolio
|
Q2 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,279,496
shares
|
$8.75 Million
0.0% of portfolio
|
Q2 2025
Added 3.03%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,276,538
shares
|
$8.73 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.05%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
1,193,410
shares
|
$8.16 Million
0.47% of portfolio
|
Q1 2025
Reduced 1.48%
|
|
|
Nextech Invest, Ltd.
Zurich, V8 |
Aug 14, 2025 Q2 2025 |
1,141,145
shares
|
$7.81 Million
1.63% of portfolio
|
Q1 2025
New holding
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
1,141,145
shares
|
$7.81 Million
2.59% of portfolio
|
Q3 2024
Reduced 6.55%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,121,138
shares
|
$7.67 Million
0.51% of portfolio
|
Q1 2025
Added 21.71%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
Aug 11, 2025 Q2 2025 |
868,897
shares
|
$5.94 Million
2.36% of portfolio
|
Q2 2025
Reduced 1.14%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
702,138
shares
|
$4.8 Million
0.0% of portfolio
|
Q2 2025
Added 8.19%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
668,233
shares
|
$4.57 Million
0.34% of portfolio
|
Q2 2025
Added 3.66%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
661,285
shares
|
$4.52 Million
0.0% of portfolio
|
Q2 2025
Added 26.11%
|